Fragment-Based Design of a Potent MAT2a Inhibitor and in Vivo Evaluation in an MTAP Null Xenograft Model.
暂无分享，去创建一个
S. Tentarelli | M. Vázquez‐Chantada | E. Chiarparin | J. Lynch | James S. Scott | C. Stubbs | U. Börjesson | G. Robb | S. Bagal | M. Sanders | L. Evans | I. Collie | M. Grondine | Tony Cheung | C. De Fusco | A. Argyrou | M. Schimpl | James M Smith | P. Narasimhan | D. Wagner | E. Underwood | M. Vázquez-Chantada